Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 431.10 1.05
Bhel 192.65 1.77
Hindalco 146.00 0.90
State Ba 2089.00 1.18
Wipro Lt 520.60 0.84
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Wintac Limited
Wintac Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524758NSE:NABloomberg:RCN@INReuters:RECO.BO
Market Lot: 1Face Value: 10ISIN Demat: INE812C01016
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
23-APR-10 Wintac announced that it has received formal approval for the ANDA from US FDA authorities for Ondansetron Hydrochloride 20 ml Injection. 03-DEC-09 Wintac today announced that its manufacturing plant at Nelamangala, Bangalore has been approved by the USFDA (food and drug administration of United States) authorities in connection with the two ANDA`s for ondansetron 2 ml injection and ondensetron 20 ml Injection. ...   More..
Business Profile Future Plans
One To One
Recent news
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2013 (12)31-Mar-2012 (12)31-Mar-2011 (12)
Net sales 207.18242.19269.49
Other Income3.431.631.04
Total Income210.61243.82270.53
Cost of goods sold239.26245.49210.21
OPBDIT-28.65-1.6760.32
PAT-172.02-53.8310.02
Gross Block---
Equity capital60.2460.2445.45
EPS (Rs.)-25.79-10.271.05
DPS (Rs.)---
BV (Rs.)---
P/E range (x)NANA23.10 - 46.67
Debt / Equity (x)---
Operating margin (% of OI)-13.6-0.722.3
Net margin (% of OI)-81.7-22.1 3.7
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
16/2, OVH Road
Basavanagudi
Bangalore
Karnataka-560 004
PHONE
(080) 2661 2792/2667 7027
FAX
- - -
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer